1. 1) Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet, 373, 1773–1779 (2009).
2. 2) Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obes. Rev., 5 (Suppl. 1), 4–85 (2004).
3. 3) Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab. Syndr. Obes., 7, 241–253 (2014).
4. 4) Majumdar SK, Inzucchi SE. Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy? Endocrine, 44, 47–58 (2013).
5. 5) Scheen AJ. Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes. Expert Opin. Drug Saf., 14, 505–524 (2015).